Standard RA treatment with disease-modifying drugs like methotrexate or biologics has proven efficacy, while GLP-1 drugs lack established disease-modifying effects for rheumatoid arthritis
Its benefits include: Accelerating wound healing and tissue regeneration in the gut lining, making it invaluable for IBD patients
Novakova K, et al
Rosas, H
The Raun 1998 study compared ipamorelin head-to-head with GHRP-2 and GHRP-6 in rats and found that at doses producing equivalent GH release, ipamorelin caused no statistically significant increase in cortisol or prolactin, while GHRP-2 and GHRP-6 produced significant elevations of both
Based on this data, our medical team, including Nurse Practitioner Rebecca Lucas, develops a tailored GLP-1 Peptide treatment plan, outlining dosage, administration method (subcutaneous injection or oral), and expected titration schedule